好想你(002582.SZ):經營範圍擬新增“食品用塑料包裝容器製品的生產與銷售”
格隆匯11月18日丨好想你(002582.SZ)公佈,隨着大眾對健康飲食的日益關注,豆製品的重要性再次凸顯出來。中國營養學會發布的《中國居民膳食指南(2022)》強調要“經常吃全穀物、大豆製品”。市場調查顯示,豆製品在國人的早餐中佔據了半壁江山。2022年,公司推出戰略新品豆菲菲,該產品憑藉“高蛋白”、“0添加”、“凍幹科技還原豆花營養和香氣”、“食品級環保包裝瓶方便攜帶”、“即衝即飲”等特點,成為了備受早餐市場關注的明星產品。為實現豆菲菲系列產品全自動化生產,保證產品包裝及時供應,滿足消費者日益增長的市場需求,公司擬擴大經營範圍,增加“食品用塑料包裝容器製品的生產與銷售”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.